Durham, NC USA

Our News on Newswise

Study Compares Cost-Effectiveness of Weight-Loss Programs and Drugs

In a cost-effectiveness analysis of commercial diet programs and pills, the Weight Watchers program and the drug Qsymia showed the best value for the money. The Jenny Craig regimen generated the greatest weight loss, but was also the most expensive...
22-Jul-2014 9:35 AM EDT

Omega 3 Fatty Acids Lessen Severity of Osteoarthritis in Mice

x-rays.png

Mice consuming a supplement of omega 3 fatty acids had healthier joints than those fed diets high in saturated fats and omega 6 fatty acids, according to Duke Medicine researchers.
11-Jul-2014 12:05 AM EDT

New Technologies Fuel Patient Participation and Data Collection in Research

The changing dynamic of health studies driven by “big data” research projects will empower patients to become active participants who provide real-time information such as symptoms, side effects and clinical outcomes, according to researchers at...
8-Jul-2014 4:00 PM EDT

DCRI and Industry Collaboration Promotes Open Data Access

Duke University, through its Duke Clinical Research Institute (DCRI), announced this week it has entered into a novel collaboration with Bristol-Myers Squibb (BMS) to promote open access to clinical information from company-sponsored studies.
24-Jun-2014 8:05 AM EDT

BPA Stimulates Growth of Breast Cancer Cells, Diminishes Effect of Treatment

Bisphenol A (BPA), a chemical commonly used in plastics, appears to increase the proliferation of breast cancer cells, according to Duke Medicine researchers presenting at an annual meeting of endocrine scientists.
23-Jun-2014 10:00 AM EDT

Air Pollution Controls Linked to Lower Death Rates in North Carolina

National and state air pollution controls that went into effect in the early 1990s coincide with decreasing death rates from emphysema, asthma and pneumonia among people in North Carolina, according to a study led by Duke University researchers.
16-Jun-2014 12:00 PM EDT

Architecture of Signaling Proteins Enhances Knowledge of Key Receptors

Shukla.png

A team of scientists from Duke Medicine, the University of Michigan and Stanford University has determined the underlying architecture of a cellular signaling complex involved in the body’s response to stimuli such as light and pain.
19-Jun-2014 12:00 PM EDT

Heparin Derivative Suppresses Neuroblastoma Tumor Growth

Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming. The study, conducted in mice and published...
11-Jun-2014 1:25 PM EDT

Our YouTube Videos